MBRX Moleculin Biotech, Inc.

Fundamentals / CIK 0001659617 / USD

Moleculin Biotech, Inc. reported $0 in revenue and a net loss of $11.42M for the trailing twelve months ended September 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MBRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$31.38MFY 2016 Revenue: $0FY 2016 Net Income: -$3.93M2016FY 2017 Revenue: $0FY 2017 Net Income: -$9.80M2017FY 2018 Revenue: $0FY 2018 Net Income: -$11.88M2018FY 2019 Revenue: $0FY 2019 Net Income: -$13.21M2019FY 2020 Revenue: $0FY 2020 Net Income: -$17.36M2020FY 2021 Revenue: $0FY 2021 Net Income: -$15.89M2021FY 2022 Revenue: $0FY 2022 Net Income: -$29.02M2022FY 2023 Revenue: $0FY 2023 Net Income: -$29.77M2023FY 2024 Revenue: $0FY 2024 Net Income: -$26.05M2024FY 2025 Revenue: $0FY 2025 Net Income: -$33.56M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $15.89M $17.73M $19.49M $18.97M $14.42M $12.76M $11.01M $9.73M $4.54M $1.50M
Total Operating Expenses $25.10M $26.64M $29.63M $30.64M $22.97M $19.74M $17.52M $15.03M $8.65M $3.88M
Operating Income -$25.10M -$26.64M -$29.63M -$30.64M -$22.97M -$19.74M -$17.52M -$15.03M -$8.65M -$3.88M
EBITDA -$25.01M -$26.52M -$29.50M -$30.51M -$22.80M -$19.54M -$17.32M -$14.96M -$8.63M -$3.88M
Interest Expense -- -- -- -- -- -- -- -- $0 $43K
Income Before Tax -$33.56M -$26.05M -- -- -- -$17.36M -$13.43M -- -- --
Income Tax Expense $0 $0 $0 $0 $0 $0 -$229K $0 $0 $0
Net Income -$33.56M -$26.05M -$29.77M -$29.02M -$15.89M -$17.36M -$13.21M -$11.88M -$9.80M -$3.93M
Basic EPS -$355,250.00 -$2,364,250.00 -$188,375.00 -$190,250.00 -$110,625.00 -$330,000.00 -$365,625.00 -$86,250.00 -$99,375.00 -$75,000.00
Diluted EPS -- -- -- -- -$110,625.00 -$330,000.00 -$365,625.00 -$86,250.00 -$99,375.00 -$75,000.00
Basic Shares Outstanding 95 11 158 153 143 53 36 138 99 52
Diluted Shares Outstanding -- -- -- -- 143 53 36 138 99 52

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $4.49M $5.45M $5.38M $5.12M $3.74M $3.60M $3.44M $4.46M
Total Operating Expenses $6.61M $7.56M $7.87M $7.53M $5.91M $5.72M $5.94M $6.64M
Operating Income -$6.61M -$7.56M -$7.87M -$7.53M -$5.91M -$5.72M -$5.94M -$6.64M
EBITDA -$6.60M -$7.55M -$7.87M -$7.52M -$5.88M -$5.69M -$5.91M -$6.61M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$6.49M -$7.63M -$12.85M $15.55M -$25.40M -$17.81M -$5.90M -$6.58M
Basic EPS -$9.59 -$700.00 -$1,770.00 -- -$340.43 -$14,340.00 -$7,900.00 --
Basic Shares Outstanding 757.9K 11.4K 8.2K -- 74.6K 1.2K 748 --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $8.88M $4.28M $23.55M $43.15M $70.90M $15.17M $10.73M $7.13M $7.71M $5.01M
Cash & Short-Term Investments $8.88M $4.28M $23.55M $43.15M $70.90M $15.17M $10.73M $7.13M $7.71M $5.01M
Accounts Receivable, Net -- -- -- -- -- -- $1.0K $56K -- --
Other Current Assets -- -- -- -- -- -- $529K -- -- --
Total Current Assets $9.69M $5.19M $26.27M $45.60M $72.50M $17.20M $13.48M $7.97M $8.30M $5.22M
Property, Plant & Equipment, Net $78K $159K $272K $275K $338K $483K $316K $463K $33K $23K
Other Non-Current Assets $900K $0 -- -- -- -- -- -- -- --
Total Non-Current Assets $12.44M $11.73M $11.94M $11.83M $11.59M $11.83M $11.75M $11.61M $11.18M $11.17M
Total Assets $22.13M $16.93M $38.22M $57.42M $84.09M $29.03M $25.23M $19.59M $19.48M $16.39M
Accounts Payable $3.51M $2.03M $2.50M $2.10M $1.36M $1.13M $2.15M $1.25M $810K $399K
Total Current Liabilities $6.85M $5.36M $6.82M $4.82M $3.62M $2.92M $3.57M $3.88M $2.21M $1.34M
Total Non-Current Liabilities $266K $358K $5.33M $412K $1.48M $8.35M $6.09M $1.44M $150K $88K
Total Liabilities $7.12M $5.72M $12.14M $5.23M $5.10M $11.27M $9.66M $5.31M $2.37M $1.43M
Total Debt (incl. Leases) $359K $478K $574K $451K $159K $277K $379K -- -- --
Common Stock $0 $0 $33K $29K $29K $69K $46K $29K $21K $12K
Retained Earnings -$206.0M -$172.4M -$131.6M -$101.8M -$72.81M -$56.92M -$39.56M -$26.36M -$14.48M -$4.67M
Accumulated Other Comp. Income $10K -$41K -- -- -- -- -- -- $0 --
Total Stockholders' Equity $15.01M $11.21M $30.93M $52.19M $78.99M $17.76M $15.57M $14.27M $17.12M $14.96M
Total Equity $15.01M $11.21M $30.93M $52.19M $78.99M $17.76M $15.57M $14.27M $17.12M $14.96M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $7.29M $7.26M $10.32M $8.88M $6.70M $7.56M $7.72M $4.28M
Cash & Short-Term Investments $7.29M $7.26M $10.32M $8.88M $6.70M $7.56M $7.72M $4.28M
Total Current Assets $8.41M $8.72M $10.96M $9.69M $7.88M $9.08M $9.34M $5.19M
Property, Plant & Equipment, Net $54K $62K $70K $78K $77K $99K $127K $159K
Other Non-Current Assets $900K $900K $900K $900K $900K $900K -- $0
Total Non-Current Assets $12.32M $12.36M $12.40M $12.44M $12.47M $12.52M $11.67M $11.73M
Total Assets $20.74M $21.09M $23.36M $22.13M $20.35M $21.59M $21.01M $16.93M
Accounts Payable $3.69M $4.34M $4.57M $3.51M $2.12M $3.72M $2.71M $2.03M
Total Current Liabilities $6.13M $9.31M $7.96M $6.85M $5.68M $7.91M $6.90M $5.36M
Total Non-Current Liabilities $112K $187K $218K $266K $41.59M $17.27M $326K $358K
Total Liabilities $6.25M $9.50M $8.18M $7.12M $47.27M $25.18M $7.22M $5.72M
Total Debt (incl. Leases) $257K $292K $326K $359K $390K $420K $450K $478K
Common Stock $1.0K $7.0K $5.0K $0 $49K $30K $14K $0
Retained Earnings -$233.0M -$226.5M -$218.8M -$206.0M -$221.6M -$196.2M -$178.3M -$172.4M
Accumulated Other Comp. Income -$93K -$64K -$52K $10K -- -- -- -$41K
Total Stockholders' Equity $14.49M $11.59M $15.18M $15.01M -$26.92M -$3.58M $13.79M $11.21M
Total Equity $14.49M $11.59M $15.18M $15.01M -$26.92M -$3.58M $13.79M $11.21M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$33.56M -$26.05M -$29.77M -$29.02M -$15.89M -$17.36M -$13.21M -$11.88M -$9.80M -$3.93M
Depreciation & Amortization $90K $126K $127K $130K $164K $200K $199K $68K $18K $6.0K
Stock-Based Compensation $1.66M $1.73M $1.98M $2.27M $2.37M $1.68M $1.54M $1.14M $707K $324K
Change in Payables $1.33M -$468K $403K $731K $235K -$1.02M $907K $436K $411K -$41K
Operating Cash Flow -$22.73M -$23.86M -$23.59M -$27.64M -$18.95M -$17.77M -$17.20M -$12.20M -$7.32M -$3.77M
Capital Expenditure $0 -$13K -$124K -$67K -$19K -$376K -$52K -$417K -$28K -$21K
Free Cash Flow -$22.73M -$23.88M -$23.71M -$27.71M -$18.97M -$18.15M -$17.25M -$12.62M -$7.35M -$3.79M
Acquisitions, Net -- -- -- -- -- -- -- -- $0 -$100K
Investing Cash Flow $0 -$13K -$124K -$67K -$19K -$374K -$51K -$417K -$28K -$121K
Common Stock Issued -- -- -- $0 $74.68M $22.56M $19.29M -- -- --
Financing Cash Flow $27.28M $4.63M $4.14M -$23K $74.72M $22.55M $20.85M $12.04M $10.06M $8.87M
Net Change in Cash $4.60M -$19.27M -$19.59M -$27.76M $55.73M $4.44M $3.60M -$580K $2.71M $4.98M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$6.49M -$7.63M -$12.85M $15.55M -$25.40M -$17.81M -$5.90M -$6.58M
Depreciation & Amortization $8.0K $8.0K $8.0K $9.0K $21K $29K $31K $31K
Stock-Based Compensation $393K $436K $380K $459K $303K $417K $485K $427K
Change in Payables -$650K -$238K $1.07M $1.29M -$1.48M $850K $676K -$520K
Operating Cash Flow -$8.97M -$6.66M -$6.11M -$5.37M -$7.22M -$5.58M -$4.56M -$5.08M
Capital Expenditure -- -- -- $0 $0 $0 $0 $0
Free Cash Flow -- -- -- -$5.37M -$7.22M -$5.58M -$4.56M -$5.08M
Investing Cash Flow $0 $0 $0 $0 $0 $0 $0 $0
Financing Cash Flow $9.03M $3.61M $7.61M $7.49M $6.38M $5.42M $8.00M $1.0K
Net Change in Cash $25K -$3.06M $1.44M $2.17M -$854K -$159K $3.44M -$5.13M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -223.6% -232.4% -96.3% -55.6% -20.1% -97.7% -84.8% -83.2% -57.3% -26.2%
Return on Assets (ROA) -151.7% -153.9% -77.9% -50.5% -18.9% -59.8% -52.3% -60.6% -50.3% -23.9%
Current Ratio 1.41x 0.97x 3.86x 9.46x 20.02x 5.89x 3.78x 2.06x 3.75x 3.88x
Quick Ratio 1.30x 0.80x 3.46x 8.95x 19.58x 5.20x 3.01x 1.85x 3.48x 3.72x
Debt to Equity 0.02x 0.04x 0.02x 0.01x 0.00x 0.02x 0.02x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -78.8% -261.7% -266.8% -223.6% -- -- -185.1% -232.4%
Return on Assets (ROA) -55.1% -143.8% -173.4% -151.7% -273.7% -172.8% -121.5% -153.9%
Current Ratio 1.37x 0.94x 1.38x 1.41x 1.39x 1.15x 1.35x 0.97x
Quick Ratio 1.19x 0.78x 1.30x 1.30x 1.18x 0.96x 1.12x 0.80x
Debt to Equity 0.02x 0.03x 0.02x 0.02x -- -- 0.03x 0.04x
Source: SEC EDGAR CompanyFacts (CIK 0001659617) · from September 30, 2015 Data through September 30, 2026 · synced Nov 21, 2026, 05:07 UTC · Open in terminal